Phase II testing of melphalan in children with newly diagnosed rhabdomyosarcoma: A model for anticancer drug development

M. E. Horowitz, E. Etcubanas, M. L. Christensen, J. A. Houghton, S. L. George, A. A. Green, P. J. Houghton

Research output: Contribution to journalArticlepeer-review

94 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II testing of melphalan in children with newly diagnosed rhabdomyosarcoma: A model for anticancer drug development'. Together they form a unique fingerprint.

Medicine and Dentistry

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology

Neuroscience